Adagene (NASDAQ:ADAG) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Adagene (ADAG) operate in?

Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Adagene Stock (NASDAQ: ADAG) stock price, news, charts, stock research, profile.

Open	$2.97
Close	$3.06
Volume / Avg.	3.07K / 33.55K
Day Range	2.97 - 3.10
52 Wk Range	1.10 - 4.38
Market Cap	$135.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	0.04%
Days to Cover	1

Recent News

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

Avi Kapoor

Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan Networks Holdings shares surged 381% to $0.3699 on Wednesday.

Avi Kapoor

Why Is Cancer Focused Adagene Stock Plummeting Today?

Adagene presents results at ASCO 2024 Gastrointestinal Cancers Symposium. ADG126, combined with Merck's Keytruda, shows limited toxicity, sustained partial responses, and a 22% overall response rate in Colorectal Cancer patients. ADAG shares currently down 47.1% at $2.0."

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Adagene Inc

Sector

Health Care

Industry

Biotechnology

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the di...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Adagene (ADAG) stock?

You can purchase shares of Adagene (NASDAQ:ADAG) through any online brokerage.

View our list of the best stock brokerages

Who are Adagene (ADAG) competitors?

Other companies in Adagene’s space includes: Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), Atossa Therapeutics (NASDAQ:ATOS), Tevogen Bio Holdings (NASDAQ:TVGN) and Regulus Therapeutics (NASDAQ:RGLS).

What is the target price for Adagene (ADAG) stock?

There is no analysis for Adagene.

What is the forecast for Adagene (ADAG) stock?

Adagene has a consensus price target of $5.00.

Current stock price for Adagene (ADAG)?

The stock price for Adagene (NASDAQ: ADAG) is $3.061 last updated June 28, 2024 at 3:50 PM EDT.

Does Adagene (ADAG) pay a dividend?

There are no upcoming dividends for Adagene.

When is Adagene (NASDAQ:ADAG) reporting earnings?

Adagene’s H1 earnings are confirmed for Thursday, August 29, 2024.

Is Adagene (ADAG) going to split?

There is no upcoming split for Adagene.

What sector and industry does Adagene (ADAG) operate in?

Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adagene

Adagene (ADAG) Forecast